Keywords: repligen, plans, pivotal, trials, autism, drug, said

Repligen plans pivotal trials of autism drug

Article | 05 November 2001

Print This

Repligen has said it intends to conduct two Phase III clinical trials ofits candidate drug for moderate-to-severe pediatric autism, secretin, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in